ERSP schools Smart Cookie on testimonials
This article was originally published in The Tan Sheet
Executive Summary
The maker of Smart Cookie meal-replacement products will modify the general performance claim and consumer testimonials in its advertising even though the Electronic Retailing Self-Regulation Program finds adequate support for the claim "lose up to 15 pounds." The National Advertising Review Council division said June 28 Smart For Life Weight Management Centers should add a "clear and conspicuous" disclosure to its "Eat Cookies. Lose Weight. It's that simple" claim so consumers know to eat a low-calorie dinner, too. The firm also should modify consumer testimonials to depict results consistent with those observed in company studies. According to ERSP's release, Boca Raton, Fla.-based Smart For Life said "in all of its future packaging and advertising" it will make the two recommended changes. ERSP's recommendations reflect the Federal Trade Commission's enforcement approach to consumer testimonials in ads. FTC in 2009 changed its guidelines on using testimonials and endorsements to include clear disclosure of typical results rather than a "results not typical" disclaimer (1"The Tan Sheet" Oct. 12, 2009)
You may also be interested in...
FTC Testimonial Guide Moves Past "Results Not Typical," Enters Blog Era
The Federal Trade Commission raised the bar on substantiation and disclosure of "typical results" in testimonials and endorsements in advertising, in a revised guide released Oct. 5
Finance Watch: LSP Dementia Fund Closes With €260m For Neurodegenerative Diseases
EQT Life Sciences completed the final close of its inaugural LSP Dementia Fund, far surpassing an initial $100m fundraising goal. Also, Resilience received a $410m commitment from the Department of Defense to fund biomanufacturing and Viking cashed in on Phase I obesity data with a $250m offering.
Bayer Relates Feeling ‘Sexy’ To Quick Relief For Allergies In Astepro Allergy Ad Campaign
Campaign featuring actress Meghann Fahy says "allergy sufferers can relieve their allergy symptoms and be more spontaneous in their romantic pursuits.” Ads launch two months after FDA granted tentative approval for two ANDAs for generic equivalents, indicating approval could come pending resolution of patent litigation.